AAP
TNDM icon

Arax Advisory Partners’s Tandem Diabetes Care TNDM Stock Holding History

Arax Advisory Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.5K Buy
5,996
+5,248
+702% +$91.6K ﹤0.01% 2809
2026
Q1 		$14.3K Buy
748
+250
+50% +$5.43K ﹤0.01% 2261
2025
Q4 		$10.9K Sell
498
-6,653
-93% -$120K ﹤0.01% 2419
2025
Q3 		$86.8K Buy
7,151
+6,675
+1,402% +$90.4K ﹤0.01% 1583
2025
Q2 		$8.87K Buy
476
+59
+14% +$1.17K ﹤0.01% 2014
2025
Q1 		$7.99K Buy
417
+400
+2,353% +$11.7K ﹤0.01% 1628
2024
Q4 		$613 Sell
17
-9
-35% -$304 ﹤0.01% 2287
2024
Q3 		$1.1K Buy
26
+10
+63% +$424 ﹤0.01% 2217
2024
Q2 		$645 Buy
+16
New +$668 ﹤0.01% 2286

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Arax Advisory Partners's TNDM Position: Q2 2026 in Review

Arax Advisory Partners increased its Tandem Diabetes Care (TNDM) stake by 702% in Q2 2026, buying an estimated $91.6K and bringing the position to 5,996 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Arax Advisory Partners first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Arax Advisory Partners held 5,996 shares of Tandem Diabetes Care worth $90.5K as of Q2 2026.
  • Arax Advisory Partners bought 5,248 Tandem Diabetes Care shares in Q2 2026, an estimated $91.6K.
  • Tandem Diabetes Care made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2809 holding.
  • Arax Advisory Partners first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.